Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

Bejarano V, Quinn M, Conaghan PG, Reece R, Keenan AM, Walker D, Gough A, Green M, McGonagle D, Adebajo A, Jarrett S, Doherty S, Hordon L, Melsom R, Unnebrink K, Kupper H, Emery P; Yorkshire Early Arthritis Register Consortium.

Arthritis Rheum. 2008 Oct 15;59(10):1467-74. doi: 10.1002/art.24106.

2.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

3.
4.

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2017 May 8;5:CD012657. doi: 10.1002/14651858.CD012657. Review.

PMID:
28481462
5.

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 Nov 17;11:CD012437. Review.

PMID:
27855242
6.

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, van den Bemt BJ.

Cochrane Database Syst Rev. 2014 Sep 29;(9):CD010455. doi: 10.1002/14651858.CD010455.pub2. Review.

PMID:
25264908
7.

Methotrexate for treating rheumatoid arthritis.

Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2. Review.

PMID:
24916606
8.

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A.

BMC Musculoskelet Disord. 2008 Apr 17;9:52. doi: 10.1186/1471-2474-9-52. Review.

10.

Adalimumab: a review of its use in rheumatoid arthritis.

Bang LM, Keating GM.

BioDrugs. 2004;18(2):121-39. Review.

PMID:
15046527
11.

Etanercept for the treatment of rheumatoid arthritis.

Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. Review.

PMID:
23728649
12.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
13.

Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2017 Mar 10;3:CD012591. doi: 10.1002/14651858.CD012591. Review.

PMID:
28282491
14.

Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.

Boyce EG, Halilovic J, Stan-Ugbene O.

Clin Ther. 2010 Sep;32(10):1681-703. doi: 10.1016/j.clinthera.2010.09.003. Review.

PMID:
21194591
15.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934
16.

A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis.

Wiens A, Correr CJ, Venson R, Otuki MF, Pontarolo R.

Rheumatol Int. 2010 Jun;30(8):1063-70. doi: 10.1007/s00296-009-1111-4. Epub 2009 Aug 26. Review.

PMID:
19707765
17.

The value of early intervention in RA--a window of opportunity.

Breedveld F.

Clin Rheumatol. 2011 Mar;30 Suppl 1:S33-9. doi: 10.1007/s10067-010-1638-5. Epub 2011 Feb 25. Review.

PMID:
21350796

Supplemental Content

Support Center